Page last updated: 2024-09-03

morphiceptin, n-me-phe(3)- and cyclic gmp

morphiceptin, n-me-phe(3)- has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(morphiceptin, n-me-phe(3)-)
Trials
(morphiceptin, n-me-phe(3)-)
Recent Studies (post-2010)
(morphiceptin, n-me-phe(3)-)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
951122,3463334,062

Protein Interaction Comparison

ProteinTaxonomymorphiceptin, n-me-phe(3)- (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chavkin, C; Wimpey, TL1

Other Studies

1 other study(ies) available for morphiceptin, n-me-phe(3)- and cyclic gmp

ArticleYear
8-Bromo-cAMP blocks opioid activation of a voltage-gated potassium current in isolated hippocampal neurons.
    Neuroscience letters, 1992, Mar-16, Volume: 137, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cyclic GMP; Depression, Chemical; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hippocampus; Ion Channel Gating; Male; Membrane Potentials; Neurons; Phosphorylation; Potassium; Potassium Channels; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu

1992